Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Novo Nordisk divulges neuropeptide Y receptor agonists

Aug. 23, 2016

Nutrinia and Morristown close deal to fund oral insulin trials

Aug. 22, 2016

FDA extends iGlarLixi NDA review following submission of additional information

Aug. 22, 2016

Kadimastem signs agreement with unnamed medical device company for diabetes-related device

Aug. 19, 2016

Data from phase I studies reported for diabetes candidate LGD-6972

Aug. 18, 2016

Targeting MondoA-directed pathway for the treatment of insulin resistance and lipotoxicity

Aug. 18, 2016

SMAD7 gene therapy may ameliorate cancer cachexia

Aug. 18, 2016

Boehringer Ingelheim Pharma patents aldosterone synthase inhibitors

Aug. 17, 2016

Six-month update on Repros' study of enclomiphene in obese secondary hypogonadal men

Aug. 16, 2016

Takeda Pharmaceutical reports MGAT2 inhibitors

Aug. 16, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 8, 2026.
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...